Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

RPL27A Is a Target for Mir-595 and Contributes to Myelodysplastic Phenotype through Ribosomal Dysgenesis

Heba A Alkhatabi, MSc, Joop Gaken, PhD, Austin Kulasekararaj, Shengjiang Tan, PhD, Farooq Malik, BSc, PhD, Alan John Warren, PhD FRCP, FRCPath, FMedSci, Thomas Seidl, David C Darling, PhD, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 1895.

https://doi.org/10.1182/blood.V124.21.1895.1895

Published: 2014

Journal Articles

Comparison of Peripheral Blood and Bone Marrow Molecular Profiling in Primary Myelodysplastic Syndromes (MDS)

Azim M Mohamedali, PhD, Joop Gaken, PhD, Momin Ahmed, MD PhD, Austin Kulasekararaj, Alexander E Smith, PhD, Farook Malik, PhD, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 4655.

https://doi.org/10.1182/blood.V124.21.4655.4655

Published: 2014

Journal Articles

Telomere Gene Complex Mutations Are Frequently Found with Shortened Telomeres in Bone Marrow Failure Syndromes and Idiopathic Pulmonary Fibrosis; Correlation with Haematological and Clinical Features

Shreyans A Gandhi, MD DNB, MRCP, FRCPath, Jie Jiang, PhD, Nana benson-Quarm, Syed A Mian, Steve Best, PhD, Austin Kulasekararaj, Judith C Marsh, MD, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 2935.

https://doi.org/10.1182/blood.V124.21.2935.2935

Published: 2014

Journal Articles

Mutation and Expression Analysis of Jumonji Genes in Myelodysplastic Syndrome & Acute Myeloid Leukaemia

Sneha Shinde, Azim M Mohamedali, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 3555.

https://doi.org/10.1182/blood.V124.21.3555.3555

Published: 2014

Journal Articles

Busulfan-Dose Escalation in Reduced Intensity Stem Cell Transplantation (RIC-HSCT) Results in Good Outcomes for Patients with MDS and AML without Increased Toxicity

Anita Sarma, MBChB, BSc, MRCP, Victoria T Potter, MD FRCPA, FRACP, Jennifer Clay, BM BS, FRACP, FRCPA, Donal McLornan, MD PhD FRCPath, Hugues de Lavallade, MD PhD, Kavita Raj, Judith C. W. Marsh, Austin Kulasekararaj, Antonio Pagliuca, MD FRCP, FRCPath, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 1236.

https://doi.org/10.1182/blood.V124.21.1236.1236

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation Achieves Long-Term Survival in a Selected CNS Lymphoma Population

Anjum Bashir Khan, MBChB, MRCP, Alesia Abigael Hunt, MBChB, Victoria T Potter, MD FRCPA, FRACP, Shireen Kassam, MBBS, Deborah Yallop, MB, BS, BSc.(hons), MRCP, FRCPath, Piers E.M. Patten, BSc, MRCP, MRCPath, PhD, Stephen Devereux, MD PhD FRCPath, Ghulam Mufti, MD DM, FRCP, FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Robert E. Marcus, MBBS, FRCP, FRCPath

Blood (2014) 124 (21): 1197.

https://doi.org/10.1182/blood.V124.21.1197.1197

Published: 2014

Journal Articles

Prognostic Factors of Long-Term Outcomes In Low- or Int-1-Risk MDS with del5q Treated with Lenalidomide (LEN): Results From a Randomized Phase 3 Trial (MDS-004)

Pierre Fenaux, MD, PhD, Aristotles Giagounidis, MD, Odile Beyne-Rauzy, MD, PhD, Ghulam Mufti, MD, DM, FRCP, FRCPath, Moshe Mittelman, MD, Petra Muus, MD, PhD, Peter te Boekhorst, MD, PhD, Guillermo Sanz, MD, PhD, Mario Cazzola, MD, Jay Backstrom, MD, Tommy Fu, PhD, Eva Hellström-Lindberg, MD, PhD

Blood (2010) 116 (21): 4027.

https://doi.org/10.1182/blood.V116.21.4027.4027

Published: 2010

Journal Articles

Evaluation of Bone Marrow Reticulin Formation in Romiplostim-Treated Adult Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

Davi d J Kuter, MD, DPhil, Ghulam Mufti, MD, Barbara Bain, MD, Robert Hasserjian, MD, Mark Rutstein, MD

Blood (2008) 112 (11): 3416.

https://doi.org/10.1182/blood.V112.11.3416.3416

Published: 2008

Journal Articles

Fanconi-Like Syndrome with Negative Chromosomal Breakages Test and High Incidence of Myelodysplasia.

Sunil Gupta, MD, Saad M.B. Rassam, MD, Madan Riyali, MD, Aloysius Y.L. Ho, MD, Ghulam Mufti, MD

Blood (2007) 110 (11): 1681.

https://doi.org/10.1182/blood.V110.11.1681.1681

Published: 2007

Journal Articles

CD4 + CD25 high Foxp3 + Regulatory T-Cells Are Correlated with Different Risk Factors in Myelodysplastic Syndrome (MDS).

Shahram Y. Kordasti, MD, Wendy Ingram, MD, Janet Hayden, RCN, David Darling, PhD, Linda Barber, PhD, Farzin Farzaneh, PhD, Ghulam Mufti, MD

Blood (2007) 110 (11): 2445.

https://doi.org/10.1182/blood.V110.11.2445.2445

Published: 2007

Journal Articles

Allogeneic SCT with Matched Related and Unrelated Donors for Patients (pts) with Refractory Anemia (RA): Improved Survival after Introduction of Reduced Intensity Conditioning (RIC) Regimens.

T.M. de Witte, MD, Ronald Brand, PhD, Anja van Biezen, Ghulam Mufti, MD, Tapani Ruutu, MD, Jurgen Finke, MD, Peter von dem Borne, MD, Antonin Vitek, MD, Michel Delforge, MD, Paolo E. Alessandrino, MD, Nicholas Harhalakis, MD, Nigel H. Russell, MD, Enric Carreras, MD, Leo F. Verdonck, MD, Dietger W. Niederwieser, MD

Blood (2006) 108 (11): 519.

https://doi.org/10.1182/blood.V108.11.519.519

Published: 2006

Journal Articles

Kinesin Family Member 20A (KIF20A) Is Specifically down Regulated in 5q- CD34+ and CD61+ Cells and Uniparental Disomy Is Not a Feature of 5q- Syndrome.

Nicholas C. Lea, PhD, Azim Mohamedali, PhD, Natalie Twine, MSc, Joop Gaken, Phd, Nigel Westwood, Phd, Wendy Ingram, MBBS, Ghulam Mufti, MD

Blood (2006) 108 (11): 2611.

https://doi.org/10.1182/blood.V108.11.2611.2611

Published: 2006

Journal Articles

CD38 Expression in B-CLL Is Dynamic and Changes Due to Contact with Activating Stimuli Found within the Leukaemic Microenvironment.

Piers E.M. Patten, MD, Andrea G.S. Buggins, PhD, Julie Richards, PhD, Andrew Wotherspoon, MD, Terry John Hamblin, MD, Ghulam Mufti, MD, Stephen Devereux, MD PhD

Blood (2006) 108 (11): 2798.

https://doi.org/10.1182/blood.V108.11.2798.2798

Published: 2006

Journal Articles

Reduced Intensity Allogeneic Transplantation Using BEAM-Alemtuzumab in Patients with Lymphoid Malignancy: Long Term Results and Impact of Intervention with DLI.

Emma P. Das-Gupta, DM, Jennifer L. Byrne, PhD, Charles Craddock, MD, Stephen Robinson, PhD, Stephen Devereux, MD, Antonio Pagliuca, MD, Grant McQuaker, DM, Andrew P. Haynes, DM, Ghulam Mufti, MD, Nigel H. Russell, MD

Blood (2005) 106 (11): 2890.

https://doi.org/10.1182/blood.V106.11.2890.2890

Published: 2005

Journal Articles

CLORETAZINE™ (VNP40101M) Is Active in Elderly Untreated Poor Risk Patients with Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS).

Francis Giles, MD, Susan O’Brien, MD, David Rizzieri, MD, Judith Karp, MD, Maureen Cooper, MD, Ghulam Mufti, MD, Bonny Johnson, MSN, Verena Karsten, PhD, Norbert Vey, MD

Blood (2005) 106 (11): 2786.

https://doi.org/10.1182/blood.V106.11.2786.2786

Published: 2005

Journal Articles

Use of a Disease-Specific Comorbidity Index To Describe Elderly Patients with Acute Myelogenous Leukemia (AML) and High Risk Myelodysplasia (MDS) Enrolled in a Phase II Study of CLORETAZINE™ (VNP40101M).

Francis Giles, MD, David Rizzieri, MD, Judith Karp, MD, Norbert Vey, MD, Khuda Khan, MD, Ghulam Mufti, MD, Diana Hudak, Verena Karsten, PhD, Susan O’Brien, MD

Blood (2005) 106 (11): 2787.

https://doi.org/10.1182/blood.V106.11.2787.2787

Published: 2005

Journal Articles

IL-2/B7.1 Fusagene Transduction of AML Blasts by a Self-Inactivating Lentiviral Vector Stimulates T Cell Responses in Vitro: A Strategy To Generate Whole Cell Vaccines for AML.

Lucas Chan, PhD, Nicola Hardwick, MPhil, Dave Darling, PhD, Joanna Galea-Lauri, PhD, Joop Gäken, PhD, Stephen Devereux, MD PhD, Mike Kemeny, PhD FRCPath, Ghulam Mufti, MD PhD DSc FRCP, Farzin Farzaneh, DPhil FRCPath

Blood (2004) 104 (11): 5275.

https://doi.org/10.1182/blood.V104.11.5275.5275

Published: 2004

Journal Articles

Gemtuzumab Ozogamicin with Donor Leucocyte Infusions Is Safe and Effective Therapy for a Subgroup of Relapsed Acute Myeloid Leukaemia and Myelodysplastic Syndrome Following Allogeneic Haemopoietic Stem Cell Transplantation (HSCT).

Kavita Raj, MD, Maadh Aldouri, MD, Aloysius Ho, MD, Antonio Pagliuca, MD, Stephen Devereux, MD, Ghulam Mufti, MD

Blood (2004) 104 (11): 1806.

https://doi.org/10.1182/blood.V104.11.1806.1806

Published: 2004

Journal Articles

High-Risk Myelodysplastic Syndrome (MDS): First Results of International Phase 2 Study with Oral Farnesyltransferase Inhibitor R115777 (ZARNESTRA TM ).

Razelle Kurzrock, MD, Pierre Fenaux, MD, Azra Raza, MD, Ghulam Mufti, MD, Carlo Aul, MD, Ulrich Germing, MD, Rene Kerstens, MD, Peter DePorre, MD

Blood (2004) 104 (11): 68.

https://doi.org/10.1182/blood.V104.11.68.68

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

RPL27A Is a Target for Mir-595 and Contributes to Myelodysplastic Phenotype through Ribosomal Dysgenesis

Comparison of Peripheral Blood and Bone Marrow Molecular Profiling in Primary Myelodysplastic Syndromes (MDS)

Telomere Gene Complex Mutations Are Frequently Found with Shortened Telomeres in Bone Marrow Failure Syndromes and Idiopathic Pulmonary Fibrosis; Correlation with Haematological and Clinical Features

Mutation and Expression Analysis of Jumonji Genes in Myelodysplastic Syndrome & Acute Myeloid Leukaemia

Busulfan-Dose Escalation in Reduced Intensity Stem Cell Transplantation (RIC-HSCT) Results in Good Outcomes for Patients with MDS and AML without Increased Toxicity

Autologous Stem Cell Transplantation Achieves Long-Term Survival in a Selected CNS Lymphoma Population

Prognostic Factors of Long-Term Outcomes In Low- or Int-1-Risk MDS with del5q Treated with Lenalidomide (LEN): Results From a Randomized Phase 3 Trial (MDS-004)

Evaluation of Bone Marrow Reticulin Formation in Romiplostim-Treated Adult Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

Fanconi-Like Syndrome with Negative Chromosomal Breakages Test and High Incidence of Myelodysplasia.

CD4 + CD25 high Foxp3 + Regulatory T-Cells Are Correlated with Different Risk Factors in Myelodysplastic Syndrome (MDS).

Allogeneic SCT with Matched Related and Unrelated Donors for Patients (pts) with Refractory Anemia (RA): Improved Survival after Introduction of Reduced Intensity Conditioning (RIC) Regimens.

Kinesin Family Member 20A (KIF20A) Is Specifically down Regulated in 5q- CD34+ and CD61+ Cells and Uniparental Disomy Is Not a Feature of 5q- Syndrome.

CD38 Expression in B-CLL Is Dynamic and Changes Due to Contact with Activating Stimuli Found within the Leukaemic Microenvironment.

Reduced Intensity Allogeneic Transplantation Using BEAM-Alemtuzumab in Patients with Lymphoid Malignancy: Long Term Results and Impact of Intervention with DLI.

CLORETAZINE™ (VNP40101M) Is Active in Elderly Untreated Poor Risk Patients with Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS).

Use of a Disease-Specific Comorbidity Index To Describe Elderly Patients with Acute Myelogenous Leukemia (AML) and High Risk Myelodysplasia (MDS) Enrolled in a Phase II Study of CLORETAZINE™ (VNP40101M).

IL-2/B7.1 Fusagene Transduction of AML Blasts by a Self-Inactivating Lentiviral Vector Stimulates T Cell Responses in Vitro: A Strategy To Generate Whole Cell Vaccines for AML.

Gemtuzumab Ozogamicin with Donor Leucocyte Infusions Is Safe and Effective Therapy for a Subgroup of Relapsed Acute Myeloid Leukaemia and Myelodysplastic Syndrome Following Allogeneic Haemopoietic Stem Cell Transplantation (HSCT).

High-Risk Myelodysplastic Syndrome (MDS): First Results of International Phase 2 Study with Oral Farnesyltransferase Inhibitor R115777 (ZARNESTRA TM ).

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only